Preparing for ICH GCP E6(R3) implementation
A guide to assessing the impact, risk and requirements of the change
Read the whitepaperDemystifying the SLR: “S” stands for systematic
A structured approach to evidence-based decision-making
Read the whitepaper
.jpeg?crop=yes&w=1665&h=876&a=0,71&itok=RI1YETlM "obesity_scan_icons"){kind=icon}
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
ICON Cares program
Expresses our passion and achievements around environmental, social and governance (ESG) efforts.
Webinars
Enhancing clinical trials in obesity by integrating COAs and DHTs
7 October 2025. Register now.
Identifying and mitigating risks in pediatric protocol development
15 October 2025. Register now.
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
22 October 2025. Register now.
